The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice.
Open accessAbstract
A newly discovered autosomal recessive mutation, generalized lymphoproliferative disease (gld), in the C3H/HeJ strain of mice, determines the development of early onset massive lymphoid hyperplasia with autoimmunity. Significant lymph node enlargement is apparent as early as 12 wk of age. By 20 wk, lymph nodes are 50-fold heavier than those of coisogenic C3H/HeJ-+/+ mice. There is a concomitant increase in the numbers of peripheral blood lymphocytes. Analysis of C3H-gld lymph node lymphocyte subsets by immunofluorescence indicates an increase in numbers of B cells, T cells, and null (Thy-1-, sIg-) lymphocytes by 6-, 15-, and 33-fold compared with congeneic control mice. Serologically, gld/gld mice develop antinuclear antibodies (including anti-dsDNA), thymocyte-binding autoantibody, and hypergammaglobulinemia with major increases in several immunoglobulin isotypes. Mutant gld mice live only one-half as long as normal controls (12 and 23 mo, respectively). Interstitial pneumonitis was found in virtually all C3H-gld mice autopsied when moribund. Although immune complexes were detected in the glomerulus by immunofluorescence techniques, only 14% of the autopsied mice had significant lupus-like nephritis. Vascular disease was not found. The pattern of early onset massive lymph node enlargement, hypergammaglobulinemia, and production of antinuclear autoantibodies resembles the basic abnormal phenotype induced by the lpr (lymphoproliferation) mutation. The mutations gld and lpr are not allelic. Linkage studies indicate that gld is located between Pep-3 and Lp on chromosome 1. This new mutation adds another genetically well-defined model to the list of murine lymphoproliferative/autoimmune disorders that may be exploited to gain a clearer understanding of immunoregulatory defects and for identifying common pathogenetic factors involved in systemic autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of enzyme electrophoresis in human genetics
Harris, H., & Hopkinson, D. A. (1976) · Cited by 2,231
Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B., & Dixon, F. J. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.5.1198 · Cited by 1,598
Self-citationThe Immunology and Pathology of NZB Mice
(1968) · Advances in Immunology · doi:10.1016/s0065-2776(08)60444-7 · Cited by 660
Marshak-Rothstein, A., Fink, P., Gridley, T., Raulet, D. H., Bevan, M. J., & Gefter, M. L. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.6.2491 · Cited by 575
Etiopathogenesis of Murine SLE1
THEOFILOPOULOS, A. N., & Dixon, F. J. (1981) · Immunological Reviews · doi:10.1111/j.1600-065x.1981.tb00343.x · Cited by 511
Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice
HELYER, B. J., & HOWIE, J. B. (1963) · Nature · doi:10.1038/197197a0 · Cited by 333
Altman, A., Theofilopoulos, A. N., Weiner, R., Katz, D. H., & Dixon, F. J. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.791 · Cited by 331
Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.
Morse, H. C., Davidson, W. F., Yetter, R. A., Murphy, E. D., Roths, J. B., & Coffman, R. L. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.6.2612 · Cited by 291
Self-citationMurphy, E. D., & Roths, J. B. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780221105 · Cited by 286
Self-citationCirculating Immune Complexes in the Idiopathic Interstitial Pneumonias
Dreisin, R. B., Schwarz, M. I., Theofilopoulos, A. N., & Stanford, R. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802162980701 · Cited by 278
Cited by
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Review: Environmental exposure to mercury and its toxicopathologic implications for public health
Tchounwou, P. B., Ayensu, W. K., Ninashvili, N., & Sutton, D. (2003) · Environmental Toxicology · doi:10.1002/tox.10116 · Cited by 1,298
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
Fas and Fas ligand: lpr and gld mutations
Nagata, S., & Suda, T. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80069-7 · Cited by 892
Microglia Promote the Death of Developing Purkinje Cells
Marı́n-Teva, J. L., Dusart, I., Colin, C., Gervais, A., van Rooijen, N., & Mallat, M. (2004) · Neuron · doi:10.1016/s0896-6273(04)00069-8 · Cited by 757
Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis
Pickering, M. C., Botto, M., Taylor, P. R., Lachmann, P. J., & Walport, M. J. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76021-x · Cited by 544
A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma
Winandy, S., Wu, P., & Georgopoulos, K. (1995) · Cell · doi:10.1016/0092-8674(95)90170-1 · Cited by 527
C-Reactive Protein as a Marker for Inflammatory Bowel Disease
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00026 · Cited by 513
Polygenic control of susceptibility to murine systemic lupus erythematosus
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., & Wakeland, E. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90100-7 · Cited by 471
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 361
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5628 · Cited by 345
Braun, M. Y., Lowin, B., French, L., Acha-Orbea, H., & Tschopp, J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.657 · Cited by 297
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell Mobilization
Angeli, V., Llodrá, J., Rong, J. X., Satoh, K., Ishii, S., Shimizu, T., Fisher, E. A., & Randolph, G. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.003 · Cited by 257
Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T., Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20132423 · Cited by 42
Metadata
- Authors
- Roths, J. B., Murphy, E. D., & Eicher, E. M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1984-01-01
- Volume
- 159
- Issue
- 1
- Pages
- 1-20
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2126715968
- Cited by
- 299
- References
- 18
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.